Semiconductors Healthcare Sector

Trevi Therapeutics

Market Cap: US$671.5m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapy Haduvio for the treatment of chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough conditions targeting the central and peripheral nervous systems.

Day One Biopharmaceuticals

Market Cap: US$667.0m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

IRADIMED

Market Cap: US$659.4m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

Dianthus Therapeutics

Market Cap: US$645.8m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

GH Research

Market Cap: US$643.9m

Together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States.

Arbutus Biopharma

Market Cap: US$641.5m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Akebia Therapeutics

Market Cap: US$638.2m

A biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.

Zhengye Biotechnology Holding

Market Cap: US$636.2m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

Savara

Market Cap: US$636.0m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Evolus

Market Cap: US$631.9m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

CeriBell

Market Cap: US$620.2m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

Simulations Plus

Market Cap: US$619.8m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Curaleaf Holdings

Market Cap: CA$863.4m

Produces and distributes cannabis products in the United States and internationally.

AbCellera Biologics

Market Cap: US$613.9m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Avanos Medical

Market Cap: US$605.8m

A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

Replimune Group

Market Cap: US$605.3m

A clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.

Beta Bionics

Market Cap: US$604.8m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

Integral Diagnostics

Market Cap: AU$938.0m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

Fulgent Genetics

Market Cap: US$599.7m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Bicycle Therapeutics

Market Cap: US$595.6m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Xencor

Market Cap: US$592.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

KalVista Pharmaceuticals

Market Cap: US$591.6m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

AnaptysBio

Market Cap: US$588.5m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Cogent Biosciences

Market Cap: US$584.5m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Iovance Biotherapeutics

Market Cap: US$584.4m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Butterfly Network

Market Cap: US$581.1m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

Tian'an Technology Group

Market Cap: US$569.0m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

Advanced Medical Solutions Group

Market Cap: UK£420.2m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

Keros Therapeutics

Market Cap: US$554.4m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Immatics

Market Cap: US$554.3m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

Owens & Minor

Market Cap: US$547.8m

Operates as a healthcare solutions company worldwide.

OrthoPediatrics

Market Cap: US$545.9m

A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.

Tyra Biosciences

Market Cap: US$545.6m

A clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States.

Regulus Therapeutics

Market Cap: US$544.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Sionna Therapeutics

Market Cap: US$543.6m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Maravai LifeSciences Holdings

Market Cap: US$539.8m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.